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Abstract
Background—Using data from four community-based cohorts of African Americans (AA), we
tested the association between genome-wide markers (SNPs) and cardiac phenotypes in the
Candidate-gene Association REsource (CARe) study.
Methods and Results—Among 6,765 AA, we related age, sex, height and weight-adjusted
residuals for nine cardiac phenotypes (assessed by echocardiogram or MRI) to 2.5 million SNPs
genotyped using Genome-Wide Affymetrix Human SNP Array 6.0 (Affy6.0) and the remainder
imputed. Within cohort genome-wide association analysis was conducted followed by meta-
analysis across cohorts using inverse variance weights (genome-wide significance threshold=4.0
×10−07). Supplementary pathway analysis was performed. We attempted replication in 3 smaller
cohorts of African ancestry and tested look-ups in one consortium of European ancestry
(EchoGEN). Across the 9 phenotypes, variants in 4 genetic loci reached genome-wide
significance: rs4552931 in UBE2V2 (p=1.43 × 10−07) for left ventricular mass (LVM); rs7213314
in WIPI1 (p=1.68 × 10−07) for LV internal diastolic diameter (LVIDD); rs1571099 in PPAPDC1A
(p= 2.57 × 10−08) for interventricular septal wall thickness (IVST); and rs9530176 in KLF5
(p=4.02 × 10−07) for ejection fraction (EF). Associated variants were enriched in three signaling
pathways involved in cardiac remodeling. None of the 4 loci replicated in cohorts of African
ancestry were confirmed in look-ups in EchoGEN.
Conclusions—In the largest GWAS of cardiac structure and function to date in AA, we
identified 4 genetic loci related to LVM, IVST, LVIDD and EF that reached genome-wide
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significance. Replication results suggest that these loci may represent unique to individuals of
African ancestry. Additional large-scale studies are warranted for these complex phenotypes.
Keywords
echocardiography; ethnic; genome-wide association studies; Left atrium genetics; left ventricular
mass genetics
Introduction
Although a number of traditional cardiovascular risk factors contribute substantially to
interindividual variation in cardiac structure and systolic function, much of the observed
variation in cardiac target organ damage is unexplained by established environmental risk
factors, and may be attributable to genetic factors.1 Both animal2–4 and human5–10 studies
support a genetic influence on left ventricular (LV) structure and function. In a relatively
recent 100K SNP genome-wide association study (GWAS) in the Framingham Heart Study,
investigators confirmed modest-to-strong heritabilities (estimates 0.30–0.52) for several
echocardiographic traits in white participants of European descent.11 More recently, Vasan
et al. conducted a GWAS using 2.5 million single nucleotide polymorphisms (SNPs) in a
combined sample of 12,612 individuals of European ancestry from 5 community-based
cohorts and identified 5 genetic loci associated with variation in phenotypes of cardiac
structure.12 Data on genetic influences on cardiac structure and function in African
Americans are quite limited. Analyses from the Hypertension Genetic Epidemiology
Network (HyperGEN), and the Genetic Epidemiology Network of Arteriopathy (GENOA)
studies suggest a high heritability of LV mass (estimates ranging from 0.55–0.88), and
genetic influences on LV geometric remodeling.8
The genome-wide association method to identify novel SNPs contributing to the underlying
risk for complex diseases has been successful.13 African American data from the Candidate-
gene Association REsource (CARe) Study allowed us to perform the first AA GWAS on




Details of the CARe consortium are described elsewhere.14 Briefly, the CARe Study
consists of 9 population-based cohort studies sponsored by the National Heart, Lung, and
Blood Institute. Within CARe, 4 cohorts with African Americans (the Atherosclerosis Risk
In Communities [ARIC], the Coronary Artery Risk Development in Young Adults
[CARDIA], the Jackson Heart Study [JHS], and the Multi-Ethnic Study of Atherosclerosis
(MESA]) had both echocardiography or MRI data, and DNA data available to investigate
genome-wide associations (GWA). These 4 cohorts were used for the discovery phase of
this investigation. Guidelines on collaboration, phenotype harmonization, covariate
selection, and the analysis plan for both within-cohort GWA and prospective meta-analysis
of results across studies were adopted by each study. Also each CARe cohort obtained
approval from the respective institutional review boards for consent procedures, examination
and surveillance components, data security measures, and DNA collection and its use for
genetic research.
Echocardiographic and MRI Methods
Details on the collection of echocardiographic and MRI data by cohort are discussed in
Appendix Section I. In 3 of the cohorts, participants underwent routine transthoracic
Fox et al. Page 3













echocardiography at selected examinations (visit1 for JHS and ARIC and visit 3 for
CARDIA). For MESA, participants underwent cardiac MRI at visit 1. For participants
undergoing echocardiography, M- mode measurements of LV internal diastolic and systolic
diameter (LVIDD and LVISD), the thickness at end-diastole of the posterior wall (PWTD)
and interventricular septum (IVSTD), and the diameter at end-systole of the aortic root
(ARD) and the LA diameter (LAD) were obtained using the American Society of
Echocardiography (ASE) guidelines. LVM was calculated by using the ASE corrected
formula by Devereux:
15
LV systolic dysfunction on echocardiogram was defined as the presence of reduced
fractional shortening (<0.29 - which corresponds to an ejection fraction of 0.50) on M-mode
or a depressed ejection fraction (<0.50) on two-dimensional echocardiography.
For MESA, LVM and LV ejection fraction were determined by cardiac MRI using 1.5-T
magnets. Specifically, LVM was determined by taking the difference between the epicardial
and endocardial areas for all slices, multiplying the result by the slice thickness and section
gap, and multipliying that result by the specific gravity of myocardium
Genotyping Methods and Imputation
Genotyping and quality control
Genotyping of all cohorts was performed at the BROAD institute of Harvard and MIT using
Affymetrix Genome-Wide Human SNP array 6.0 (Affy6.0), which interrogates
simultaneously 1.8 million markers for genetic variation (906,600 SNPs and 946,000 copy
number variation probes) under the CARe consortium.16 Quality control of genotyped data
(SNPs) was performed using the BROAD genetic analysis platform (GAP) that consists of
PLINK17 and Birdseed v1.3316 software. Quality control measures included removal of
samples with genotyping success rate <95%, monomorphic SNPs, SNPs that mapped to
several loci in the human genome, and SNPs with minor allele frequency (MAF) <1%.
Samples with very low (< 4 standard deviation units, SD) heterozygosity suggesting poor
DNA quality and samples with very high (> 4 SD) heterozygosity suggesting sample
contamination were also removed. In all cohorts except for JHS, relatedness was identified
by computing identical by descent (IBD) and identical by state (IBS) scores across the
datasets. All pairs that shared ≥5% of their genome were removed, as were samples that did
not cluster well when subjected to multidimensional scaling (MDS) or genome-wide
“neighbor” analysis in PLINK. This was done to eliminate familial correlation. For the
family-based sub cohort of the JHS, early analytical assessment by CARe investigators
found little effect on inflation factor due to familial correlation. Other quality control filters
included removing SNPs: for which genotype missingness can be predicted by surrounding
haplotypes; with Mendelian inconsistencies and those with significant deviation from
Hardy-Weinberg equilibrium. In total, 113,238 SNPs were excluded in ARIC; 69,710 in
CARDIA; 40,653 in JHS; and 27,956 in MESA i.e. >99% genotyping success rate.
Genotype imputation
Genotype imputation performed in CARe has been detailed elsewhere. Briefly, in CARe,
imputation was performed using the MACH http://www.sph.umich.edu/csg/abecasis/
MaCH/) program with HapMap phase 2 (build 36 release 22) as input. Since the African-
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American population is admixed with the proportion of European ancestry estimated to be
~17–19%,18, 19 an artificial reference panel consisting of equal proportions of the YRI and
CEU HapMap phased haplotypes (using only SNPs found in both YRI and CEU panels, i.e.
~2.2M SNPs) was constructed. Hao et al. suggested that the accuracy of using the mixed
panel for African-Americans is comparable to the accuracy reported when imputing a
population of Nigerians using YRI as a reference panel.20
Statistical Methods
Because participants within and between cohorts were unrelated, we used logistic or linear
regression (implemented in PLINK genetic software) to investigate the association of SNP
alleles with dichotomous or continuous echo trait, respectively assuming an additive genetic
model. Fractional shortening and ejection fraction were the only 2 dichotomous cardiac
traits. In these 2 traits, we compared cases to controls while adjusting for age, sex, weight,
height and site (for CARDIA and MESA cohorts only) after excluding participants who had
a previous myocardial infarction. For the 7 continuous traits (LVM, PWTD, IVSTD,
LVIDD, LVISD, LAD, ARD), we used linear regression of log-transformed measures to
obtain sex-specific residuals after adjusting for age, weight and height. The sex-specific
residuals were then pooled, and within-cohort linear associations of SNP alleles with each
echocardiographic continuous trait were performed. Ten principal components calculated
from selected ancestry informative markers were used to account for population
stratification common in African Americans due to admixture.
Genomic control correction was applied in each study prior to the meta-analysis, which
ensured that the inflation factor lambda (λ) is maintained around unity.
Within-cohort genome-wide association results included parameter estimates (beta
regression coefficient and their standard errors). Meta-analysis was conducted using
METAL software (http://www.sph.umich.edu/csg/abecasis/metal/.). For each SNP, METAL
calculated an overall beta estimate, z-statistic and p-value from the weighted average of
individual’s statistic. No filtering on minor allele frequency was used.
A priori genome-wide statistical significance threshold of ≤ 4.0 × 10−07 was chosen to
represent the probability for at least one SNP to have a p-value below a very stringent
threshold. This strategy has been employed in GWA studies to reduce false discovery
rates.12, 21
Pathway analysis
We assigned the overall association significance of each genetic variant to the cardiac
structure equivalent to the most significant p-value among the nine cardiac traits. We then
mapped these genetic variants back to the human genome (NCBI Build 36, 2006) and
RefSeq genes. A gene region was defined as between 110kb upstream and 40kb downstream
of the gene’s most extreme transcript boundaries, which would encompass the majority of
its cis-eQTLs.22 The lowest p-value of SNPs within the gene region was assigned as the
significance score for the gene. Of the 22,374 genes evaluated, 1718 reached significance
scores less than 1.0 × 10−4 These genes were then imported into Ingenuity IPA for pathway
analysis (Ingenuity Systems, Redwood, CA). Fisher’s exact test was used to justify the
enrichment significance of each of the canonical pathways.
Replication analysis in Cohorts of African and European Ancestry and Reciprocal Look-
ups of Top Loci in Cohorts of European Ancestry
Genome-wide significant SNPs discovered in the meta-analysis of the three cohorts were
subjected to replication analysis in three cohorts of African ancestry (GENOA, N=651;
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HyperGEN, N=1316; CHS, N=501) and one cohort of European ancestry (Echo Genetics-
EchoGEN; N=12,612). We adopted a criterion for declaring significance in the replication
analysis at significance level p≤ 0.05/number of SNPs sent for replication. Additionally, we
performed a look-up of the top 50 CARe hits in the EchoGEN cohort. Subsequently, we
tested the five published genome-wide significant SNPs from the EchoGEN cohort analysis
in our CARe AA sample.
Results
The demographic and clinical characteristics of the 4 populations in the discovery meta-
analysis are summarized in Table 1. The age range for most of the participants was
comparable, except for CARDIA that had younger participants (<31 years old) overall. Of
the 4 cohorts, only JHS had all 9 echocardiographic phenotypes, the remaining 3 cohorts
measured different subsets of phenotypes. Magnetic resonance imaging was available in
MESA only.
The per-cohort genomic inflation factor (λ) was consistently below 1.02 for all traits
studied. The post-meta-analytic λ was also below 1.02, indicating absence of systematic
inflation. The meta-analysis quantile-quantile (Q-Q) plots of observed against expected p-
value distributions are shown in Appendix, Section IV, Supplementary Figure 1 (Panels A–
H).
We identified 4 genome-wide significant loci associated with LV mass, IVST, LV internal
diastolic diameter and LV ejection fraction< 0.50 (Table 2). Genetic effects (β) and standard
errors (SE), minor and major alleles, minor allele frequency, SNP type and the nearest genes
(within ~500 kbp of either site of the SNP) are also shown in Table 2. Figure 1 (Panels A–
D) summarizes the primary findings from meta-analysis and displays the genome-wide
−log10 p values for interrogated SNPs across the 22 autosomal chromosomes separately for
the four cardiac traits that were significantly associated with the four loci. Figure 2 (Panel
A–D) shows the forest plots associated with the top loci. Beta coefficients (for continuous
traits: LV mass, IVST and LV diastolic diameter) and odds ratios (for the dichotomous trait
LV ejection fraction < 0.50) from each cohort analysis and from the meta-analysis are
shown. Figure 3 (Panels A–D) shows the regional plots for the four top SNPs. The nearest
gene loci to the top SNPs within 500kb are also shown.
Appendix, Section IV, Supplementary Table I lists 7 additional top genetic loci (and the
SNP at each locus with the lowest p value) associated with cardiac traits based on the
criterion 5.0 × 10−07< p < 9.9 × 10−07 (arbitrary threshold). In Appendix, Section IV,
Supplementary Figure 2 (Panels A–G), the regional plots of the 7 additional top loci are
presented.
Pathway analysis
We examined the interaction and relationship between the top GWAS loci. Accumulating
evidence suggests that complex diseases and traits usually result from the incremental
effects of many genetic variants.23–25 Pathway analysis provides a potential route to
investigate the collective effects of multiple genetic variants on biological systems.26–28
A total of 1718 genes were found moderately related to cardiac structure. Ingenuity IPA
(Ingenuity Systems, Redwood, CA) was used to study if these genes were significantly
enriched in some specific biological pathways beyond that expected from random
distribution. Our analysis reveals that three canonical pathways were most significantly
enriched with cardiac related genes, including the sonic hedgehog signaling pathway [6
CARe genes/33 total genes in the pathway (18.2%), p=1.88×10−2], the cardiac β-adrenergic
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signaling pathway [16 CARe genes/151 total genes in the pathway (10.6%), p=3.22×10−2],
and the oncostatin M signaling [6 CARe genes/35 total genes in the pathway (17.1%),
p=3.88×10−2]. The results suggest that the disruption of these signaling pathways might be
the potential mechanisms affecting cardiac structure and related echocardiographic traits,
which are also implicated in previous studies. A table showing the list of the gene symbols
and names from the CARe dataset identified in each of the three pathways is shown in
Appendix, Section IV, Supplementary Table II.
We applied the same pathway approach to EchoGen dataset, and identified 942 cardiac-
related genes with p <1.0×10−4 (see Methods). Only a small proportion of them (97 genes)
were also classified as cardiac related genes from CARe dataset due to factors such as the
sample size and population stratification. Interestingly, one of the most enriched pathways
from CARe dataset, cardiac β-adrenergic signaling pathway, was also moderately enriched
in the EchoGen dataset (p=0.069). (Appendix, Section IV, Supplementary Figure 3)
Independent replication of top CARe SNPs in cohorts of African and
European Ancestry
Replication cohorts for the study are described in detail in Appendix Section II,
Supplementary. The four top genome-wide significant SNPs in the CARe analyses were
submitted for lookup in four AA cohorts the GENOA study (n=651), the HyperGEN study
(n=1316), and CHS (n =501). Additionally top SNPs were submitted for lookup in one large
cohort of EA individuals [EchoGEN (n= 12,612)]. None of the top SNPs met the a priori
criteria for replication in the meta-analysis of AA cohorts after correcting for multiple
comparisons. None of three SNPs available in EchoGEN (rs4552931, rs7213314, and
rs9530176) replicated.
Reciprocal Look-ups of Top Loci in cohorts of European Ancestry
We tested the top 50 CARe SNPs for each trait in the EchoGen consortium (exclusively
European ancestry). There was a moderate association between nine of the CARe SNPs and
key phenotypes of cardiac structure in EchoGen. Specifically, rs13241730 (ARD,
p=1.18×10−5) was associated with systolic dysfunction (p=0.00925); rs11187518 (EF,
p=4.44×10−6) with LV wall thickness (p= 3.94×10−5); rs7159121 (FS, p=4.67×10−6) with
FS (p=0.000862); rs1549850 (ISD, p=1.36×10−5) with ARD (p=0.00142); rs4752424
(LVSTD, p=1.95×10−5) with LVM (p=0.00088); rs11758777 (LAD, p=9.29×10−6) with left
atrial size (p= 0.00911), rs9536417 (LVDD, p=1.19×10−5) with FS (p=0.00113); rs6907666
(LVM, p= 1.45×10−5) with ARD (p= 0.000566); and rs33432 (PWT, p= 1.94×10−5) with
LVDD (p=0.0106). We tested whether the top 5 hits from EchoGEN replicated in CARe and
did not find replication of any of the 5 SNPs.
Discussion
In this largest African American study assessing the influence of genetic variation on cardiac
structure and function, we identified 4 genome-wide significant loci associated with LV
structure (1 SNP for LV mass, 1 SNP for IVST, and 1 for LV internal diastolic dimension)
and 1 significant locus associated with LV systolic dysfunction based on LV ejection
fraction <0.50 or fractional shorting < 0.29. Findings from the replication analysis of the
four genome-wide significant loci in European ancestry suggest that these SNPs may
represent loci specific to African ancestry. In further analysis, we found that nine of the top
50 hits were noted to be moderately associated with cardiac structure in a large European
ancestry cohort.
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All of the genome wide significant loci and a number of the other top loci identified that
were near (but did not reach) the threshold for genome-wide significance were near genes
that can be linked to biological pathways implicated in influencing cardiac structure and
function. Descriptions of these loci and nearby genes are noted in Appendix, Section V and
Section VI.
In a pathway analysis we noted top loci were enriched in cardiac genes from three signaling
pathways (the sonic hedgehog pathway, the cardiac β-adrenergic signaling pathway and the
oncostatin M signaling pathway). Genes in the sonic hedgehog pathway have been identified
in the adult heart and probably plays a role in normal cardiac homeostasis and function. This
pathway is key in the embryonic development of the coronary vasculature. Several genes in
the β-adrenergic signaling pathway were represented among the top hits. It is established
that this pathway is important in the induction and maintenance of cardiac hypertrophy, in
the redistribution of myosin isoforms, and in cardiac contractility. Further supporting our
finding in the adrenergic pathway is that a similar analysis performed in the EchoGen
consortium also revealed genes moderately enriched in this pathway. Finally, the oncostatin
M signaling pathway was identified in the supplemental analysis. Oncostatin M is an
inflammatory mediator; the signaling pathway involving oncostatin M has been found to
induce stromal derived factor-1 protein secretion in human cardiac cells and play a role in
repair and tissue regeneration.
Our results suggest that population stratification may complicate the discovery of genetic
variants associated with cardiac structure and function, despite the evidence of shared
mechanisms. It is thus necessary to investigate genetic variants specific to AA.
Strengths and Limitations
The fact that there was no replication of the top loci in populations of European ancestry
suggests that the association of these loci with cardiac structure and function may be unique
to African ancestry. One limitation to replication is that the African American community
represents an admixed population with smaller LD blocks compared to those of European
ancestry. There is significant heterogeneity among individuals within the ethnic group.
Therefore, replicating findings of our study population is more challenging compared to
those from cohorts of European ancestry despite the use of ancestral informative markers.
Because HyperGEN and GENOA are family studies ascertained on hypertension, and
therefore, enriched with genes that contribute to elevated blood pressure (assuming blood
pressure is genetically determined, which remains the prevailing thought) it is not
completely unexpected that our results did not replicate in these cohorts. These families
might have a distinct ‘hypertension-induced” phenotype. Another limitation of the current
study is that differences in study design and data collection between cohorts may lower our
statistical power to detect modest genetic effects in GWA. Using GWA, we are focused on
detecting multiple variants with small effects that influence complex diseases; our statistical
power in this study to detect rare variants associated to phenotypes of cardiac structure and
function is limited. Additionally, we acknowledge that we are only able to identify an
association between genetic loci and phenotypes of interest; we are not able to establish a
cause-effect relation or to identify a mechanism leading to the association. Finally, the
cohorts studied were all of African ancestry descent, limiting the generalizability of our
findings to individuals of non-African ancestry.
These limitations are balanced against our ability to conduct the largest GWA on the African
Americans with participants from community-based cohorts (each using standardized
methods of M-mode echocardiography or MRI with quality control procedures in individual
imaging laboratories) and with harmonization of imputation strategies and analytical
methods into a prospective meta-analysis.
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Our prospective meta-analysis of cardiac structure and function from over 6,765 participants
in four community-based cohorts identified four loci rs4552931 in UBE2V2 on chromosome
8 for left ventricular mass, rs7213314 in WIPI1 on chromosome 17 for left ventricular
internal diameter in diastole, rs1571099 in PPAPDC1A) on chromosome 10 for
interventricular septal wall thickness; and rs9530176 in KLF5 on chromosome 13 for
ejection fraction.
In a pathway analysis, top loci in the meta-analysis were significantly enriched with genes
from the sonic hedgehog signaling pathway, the cardiac β-adrenergic signaling pathway and
the oncostatin M signaling pathway.
After testing the top 50 CARe SNPs for each trait in the EchoGen consortium, we observed
moderate association between nine of these SNPs with cardiac structure in EchoGen.
Implications
Identification of genetic variations that contribute to cardiac structure and function through
GWA analysis may help us better understand the role genes play in development and
progression of cardiac end organ damage in African Americans. This is particularly
important given the current racial disparity in LV hypertrophy and dysfunction (both of
which are predictors of cardiovascular morbidity and mortality). Findings in this study
warrant further investigation including replication analysis in much larger samples, and
identification of potential biological mechanisms explaining the association of these variants
to phenotypic findings on cardiac imaging.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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HB-97068, N01-HB-97069), New England Research Institute (N01-HB-97073), Interfaith Medical Center-
Brooklyn (N01-HB-97085); Coronary Artery Risk in Young Adults (CARDIA): University of Alabama at
Birmingham (N01-HC-48047), University of Minnesota (N01-HC-48048), Northwestern University (N01-
HC-48049), Kaiser Foundation Research Institute (N01-HC-48050), University of Alabama at Birmingham (N01-
HC-95095), Tufts-New England Medical Center (N01-HC-45204), Wake Forest University (N01-HC-45205),
Harbor-UCLA Research and Education Institute (N01-HC-05187), University of California, Irvine (N01-
HC-45134, N01-HC-95100); Framingham Heart Study (FHS): Boston University (N01-HC-25195); Jackson
Heart Study (JHS): Jackson State University (N01-HC-95170), University of Mississippi (N01-HC-95171),
Tougaloo College (N01-HC-95172); Multi-Ethnic Study of Atherosclerosis (MESA): University of Washington
(N01-HC-95159), Regents of the University of California (N01-HC-95160), Columbia University (N01-
HC-95161), Johns Hopkins University (N01-HC-95162), University of Minnesota (N01-HC-95163), Northwestern
University (N01-HC-95164), Wake Forest University (N01-HC-95165), University of Vermont (N01-HC-95166),
New England Medical Center (N01-HC-95167), Johns Hopkins University (N01-HC-95168), Harbor-UCLA
Research and Education Institute (N01-HC-95169); Sleep Heart Health Study (SHHS): Johns Hopkins University
(U01 HL064360), Case Western University (U01 HL063463), University of California, Davis (U01 HL053916),
University of Arizona (U01 HL053938), University of Minnesota (relocating in 2006 to University Arizona) (U01
HL053934), University of Pittsburgh (U01 HL077813), Boston University (U01 HL053941), MedStar Research
Institute (U01 HL063429), Johns Hopkins University (U01 HL053937).
Replication Cohorts
EchoGEN: The support for the Echo Genetics cohort is listed by study:
Cardiovascular Health Study: Contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01
HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, grant numbers U01 HL080295 and R01 HL087652
from the National Heart, Lung, and Blood Institute. DNA handling and genotyping was supported in part by
National Center for Research Resources grant M01RR00069 to the Cedars-Sinai General Clinical Research Center
Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the
Southern California Diabetes Endocrinology Research Center.
Rotterdam Study: The genome-wide association’s database of the Rotterdam Study was funded through the
Netherlands Organization of Scientific Research NWO (nr. 175.010.2005.011, 911.03.012) and the Research
Institute for Diseases in the Elderly (RIDE).
This study was supported by the Netherlands Genomics Initiative (NGI)/NWO project number 050 60 810. The
Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands
organization for scientific research (NWO), the Netherlands Organization for Health Research and Development
(ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Netherlands Heart Foundation, the
Ministry of Education, Culture and Science, the Ministry of Health, Welfare and Sports, the European Commission
(DG XII), and the Municipality of Rotterdam. We thank Michael Moorhouse, PhD, Department of Bioinformatics,
and Pascal Arp, BSc, Mila Jhamai, BSc, Marijn Verkerk, BSc, and Sander Bervoets, BSc, Department of Internal
Medicine, Erasmus MC, Rotterdam, the Netherlands, for their help in creating the database.
MONICA-KORA: The study was funded by the European Union sponsored project Cardiogenics (LSHM-CT
2006-037593), by the National Genome Network (01GS0418 to Drs Schunkert and Erdmann; 01GR0466 to Dr
Ziegler) and by the National Genome Network Plus sponsored by the German Federal Ministry of Education and
Research (BMBF). The MONICA/KORA Augsburg studies were financed by the Helmholtz Zentrum München
(former GSF)–National Research Center for Environmental Health, Neuherberg, Germany, and supported by grants
from the BMBF and Munich Center of Health Sciences (MC Health) as part of LMUinnovativ.
Framingham Heart Study: This work was supported by the National Heart, Lung, and Blood Institute’s
Framingham Heart Study (Contract No. N01-HC- 25195) and its contract with Affymetrix, Inc for genotyping
services (Contract No. N02-HL-6-4278), and by grants from the National Heart, Lung, and Blood Institute
2K24HL04334, RO1HL080124, RO1HL077477, and R01HL093328 (all to Dr. Vasan).
Gutenberg Heart Study: The Gutenberg Heart Study is funded through the government of Rheinland- Pfalz
(“Stiftung Rheinland Pfalz für Innovation,” contract number AZ 961-386261/733), the research programs “Wissen
schafft Zukunft” and “Schwerpunkt Vaskuläre Prävention” of the Johannes Gutenberg-University of Mainz and its
contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the
Gutenberg Heart Study. Specifically, the research reported in this article was supported by the National Genome
Network “NGFNplus” (contract number project A3 01GS0833) by the Federal Ministry of Education and Research,
Germany.
Study of Health in Pomerania (SHIP): SHIP is funded by the Federal Ministry of Education and Research (grants
No. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the
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Federal State of Mecklenburg-West Pomerania. Echocardiography in the 5-year follow- up was funded by the
Competence Network Heart Failure of the Federal Ministry of Education and Research, and statistical analyses
were supported by Deutsche Forschungsgemeinschaft (by grant SFB TR 19). Genome-wide data have been
supported by the Federal Ministry of Education and Research (grant No.03ZIK012) and a joint grant from Siemens
Healthcare, Erlangen, Germany, and by the Federal State of Mecklenburg- West Pomerania.
Austrian Stroke Prevention Study: Current analyses of the Austrian Stroke Prevention Study are funded by the
Austrian Science Fund Project P20545_P05 Genetics of cerebral small vessel disease (Dr H. Schmidt).
Mayo Clinic, Olmsted County: Dr Rodheffer was supported in part by RO1 HL55502.
GENOA: Genetic Epidemiology Network of Arteriopathy (GENOA) study is supported by the National Institutes
of Health, grant numbers HL087660 and HL100245 from National Heart, Lung, Blood Institute, and MD002249
from National Institute on Minority Health and Health Disparities.” Kristin Meyers received additional funding
through the National Center for Advancing Translation Sciences (NCATS) grant 9U54TR000021.
HyperGEN : The HyperGEN network is funded by cooperative agreements (U10) with the National Heart, Lung,
and Blood Institute: HL54471, HL54472, HL54473, HL54495, HL54496, HL54497, HL54509, HL54515, and 2
R01 HL55673-12.
Role of the Sponsor: The funding sources had no role in the study design, analyses, or drafting of the manuscript.
The NHLBI reviews all manuscripts submitted for publication but it was not involved in the decision to publish.
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Manhattan plots showing the genome-wide −log10 p values for interrogated single
nucleotide polymorphisms across the 22 autosomal chromosomes for (A) left ventricular
Fox et al. Page 14













mass, (B) left ventricular internal diastolic diameter, (C) interventricular septal wall
thickness, (D) and left ventricular ejection fraction. Chr; Chromosome
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Forest plots for (A) left ventricular mass, (B) left ventricular internal diastolic diameter, (C)
interventricular septal wall thickness, and (D) left ventricular ejection fraction are shown.
For each cardiac trait the odds ratios are shown for cohort specific analyses and for the
meta-analysis. ARIC, Atherosclerosis Risks in Communities Study; CARDIA, Coronary
Artery Risk Development in Young Adults; JHS, Jackson Heart Study; MESA, Multi-Ethnic
Study of Atherosclerosis; Chr; Chromosome
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“Results (−log10 P) are shown for SNPs in the region flanking 250kb on either side of the
marker SNPs. The marker SNPs and r2 values of other SNPs are shown in red color. The
genes within the region of interest are annotated and are shown in green arrow We
investigated the association between genome-wide markers with cardiac structure and
systolic function using data from four community-based cohorts of African Americans in the
Candidate-gene Association Resource study. Findings from this analysis may help us better
understand the role genes play in development and progression of cardiac end organ damage
in African Americans. This is particularly important given the current racial disparity in LV
hypertrophy and dysfunction (both of which are predictors of cardiovascular morbidity and
mortality). Findings in this study warrant further investigation including replication analysis
in much larger samples, and identification of potential biological mechanisms explaining the
association of these variants to phenotypic findings on cardiac imaging.
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